Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer. - van Wilpe S; Taha T; Rothmann EC; Altshuler E; Park J; Ledet EM; Rothermundt C; Bergman AM; Willemsen AECAB; Tsantoulis P; Oldenburg J; Bernard-Tessier A; et al. (European urology oncology, 2025)